| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 186 |
| 1 | TACROLIMUS | 173 |
| 2 | MYCOPHENOLATE MOFETIL | 168 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 163 |
| 4 | TACROLIMUS OINTMENT 0.1% | 163 |
| 5 | PREDNISONE | 136 |
| 6 | METHOTREXATE SODIUM | 102 |
| 7 | ETANERCEPT | 96 |
| 8 | METHOTREXATE | 94 |
| 9 | ETONOGESTREL AND ETHINYL ESTRADIOL | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 4 | 0.0115 |
| 1 | CIDOFOVIR ANHYDROUS | 12 | 0.0083 |
| 2 | FINGOLIMOD HYDROCHLORIDE | 33 | 0.0065 |
| 3 | IMIQUIMOD | 10 | 0.0043 |
| 4 | ETONOGESTREL AND ETHINYL ESTRADIOL | 89 | 0.0040 |
| 5 | MYCOPHENILIC ACID | 43 | 0.0020 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| 7 | MYCOPHENOLIC ACID | 46 | 0.0014 |
| 8 | SIROLIMUS | 18 | 0.0013 |
| 9 | TACROLIMUS OINTMENT 0.1% | 163 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 268 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 177 |
| 2 | Progestin [EPC] | 160 |
| 3 | Estrogen [EPC] | 110 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 94 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 90 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 82 |
| 7 | Purine Antimetabolite [EPC] | 67 |
| 8 | Progestin-containing Intrauterine System [EPC] | 61 |
| 9 | Alkylating Drug [EPC] | 54 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 35 | 0.0025 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 43 | 0.0020 |
| 3 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 6 | 0.0012 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 21 | 0.0011 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 5 | 0.0011 |
| 6 | Copper-containing Intrauterine Device [EPC] | 51 | 0.0010 |
| 7 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 8 | Interferon gamma [EPC] | 1 | 0.0007 |
| 9 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |